David Molkentine

1.3k total citations
30 papers, 708 citations indexed

About

David Molkentine is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Molkentine has authored 30 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Molkentine's work include Cancer-related Molecular Pathways (16 papers), Colorectal and Anal Carcinomas (5 papers) and Lung Cancer Treatments and Mutations (5 papers). David Molkentine is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Colorectal and Anal Carcinomas (5 papers) and Lung Cancer Treatments and Mutations (5 papers). David Molkentine collaborates with scholars based in United States, India and Switzerland. David Molkentine's co-authors include Uma Raju, Luka Milas, John V. Heymach, Jeffrey N. Myers, Heath D. Skinner, Uma Giri, Oliver Riesterer, David R. Valdecanas, Raymond E. Meyn and Jessica M. Molkentine and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

David Molkentine

29 papers receiving 701 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Molkentine 371 357 186 125 101 30 708
Hoa Q. Trummell 305 0.8× 360 1.0× 176 0.9× 94 0.8× 93 0.9× 19 620
Konrad Klinghammer 235 0.6× 310 0.9× 181 1.0× 125 1.0× 133 1.3× 53 580
Elvire Pons‐Tostivint 238 0.6× 468 1.3× 351 1.9× 134 1.1× 81 0.8× 47 764
Zizhen Feng 671 1.8× 272 0.8× 140 0.8× 145 1.2× 37 0.4× 23 1.0k
Vincent J. Bakanauskas 685 1.8× 428 1.2× 230 1.2× 219 1.8× 59 0.6× 8 975
Ulla Kasten-Pisula 538 1.5× 389 1.1× 300 1.6× 197 1.6× 40 0.4× 17 883
Mariko Mihara 745 2.0× 674 1.9× 203 1.1× 230 1.8× 209 2.1× 38 1.3k
Bernhard Heinrich 160 0.4× 439 1.2× 187 1.0× 66 0.5× 45 0.4× 36 630
A. D. Colevas 355 1.0× 391 1.1× 113 0.6× 55 0.4× 27 0.3× 24 652

Countries citing papers authored by David Molkentine

Since Specialization
Citations

This map shows the geographic impact of David Molkentine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Molkentine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Molkentine more than expected).

Fields of papers citing papers by David Molkentine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Molkentine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Molkentine. The network helps show where David Molkentine may publish in the future.

Co-authorship network of co-authors of David Molkentine

This figure shows the co-authorship network connecting the top 25 collaborators of David Molkentine. A scholar is included among the top collaborators of David Molkentine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Molkentine. David Molkentine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bao, Riyue, Phillip M. Pifer, David Molkentine, et al.. (2024). Th2 Cells Are Associated with Tumor Recurrence Following Radiation. Cancers. 16(8). 1586–1586. 2 indexed citations
2.
Pifer, Phillip M., Liangpeng Yang, Manish Kumar, et al.. (2023). FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner. Clinical Cancer Research. 30(1). 187–197. 13 indexed citations
3.
Basu, Sreyashi, et al.. (2023). Non-Canonical p16-SP1 Signaling in Head and Neck Cancer Potentially Affects Cell Plasticity. International Journal of Radiation Oncology*Biology*Physics. 117(2). e228–e228. 1 indexed citations
4.
Molkentine, David, Jessica M. Molkentine, Kathleen A. Bridges, et al.. (2021). p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer Research. 82(5). 916–928. 22 indexed citations
5.
Pifer, Phillip M., Manish Kumar, Liangpeng Yang, et al.. (2021). Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner. International Journal of Radiation Oncology*Biology*Physics. 111(3). S86–S87. 1 indexed citations
6.
Molkentine, Jessica M., David Molkentine, Kathleen A. Bridges, et al.. (2020). Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints. International Journal of Radiation Biology. 97(8). 1121–1128. 29 indexed citations
7.
Kumar, Manish, Liangpeng Yang, David Molkentine, et al.. (2017). BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer. Clinical Cancer Research. 24(3). 600–607. 20 indexed citations
8.
Skinner, Heath D., Uma Giri, Liang Yang, et al.. (2017). Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer. Clinical Cancer Research. 23(11). 2713–2722. 86 indexed citations
9.
Skinner, Heath D., Uma Giri, Liang Yang, et al.. (2016). Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer. Clinical Cancer Research. 22(18). 4643–4650. 55 indexed citations
10.
Wang, Li, Zhifei Wen, Marco van Vulpen, et al.. (2016). Biological responses of human solid tumor cells to X‐ray irradiation within a 1.5‐Tesla magnetic field generated by a magnetic resonance imaging–linear accelerator. Bioelectromagnetics. 37(7). 471–480. 11 indexed citations
11.
Zhang, Peijing, David Molkentine, Jessica M. Molkentine, et al.. (2016). TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects. Oncogene. 36(6). 820–828. 39 indexed citations
12.
Rabin, Tatiana, Ritsuko Komaki, Uma Raju, et al.. (2014). Preclinical Studies of Metformin Reveal Radiosensitization for Human Small Cell Lung Cancer In Vitro But Apparent Antagonism In Vivo. International Journal of Radiation Oncology*Biology*Physics. 90(1). S656–S657. 2 indexed citations
13.
Bhardwaj, Vikas, Yanai Zhan, María Angélica Cortez, et al.. (2012). C-Met Inhibitor MK-8003 Radiosensitizes c-Met–Expressing Non–Small-Cell Lung Cancer Cells With Radiation-Induced c-Met–Expression. Journal of Thoracic Oncology. 7(8). 1211–1217. 38 indexed citations
14.
Raju, Uma, Oliver Riesterer, Zhiqiang Wang, et al.. (2012). Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiotherapy and Oncology. 105(2). 241–249. 48 indexed citations
15.
Sano, Daisuke, Fumihiko Matsumoto, David R. Valdecanas, et al.. (2011). Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro. Clinical Cancer Research. 17(7). 1815–1827. 59 indexed citations
16.
Moeller, Benjamin J., John S. Yordy, Michelle D. Williams, et al.. (2011). DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy. Clinical Cancer Research. 17(7). 2035–2043. 75 indexed citations
17.
Wang, Li, Uma Raju, Luka Milas, et al.. (2011). Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells.. PubMed. 31(6). 2141–8. 36 indexed citations
18.
Torres, Mylin A., Uma Raju, David Molkentine, et al.. (2010). AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo. Investigational New Drugs. 29(4). 554–561. 21 indexed citations
19.
Riesterer, Oliver, Qiuan Yang, Uma Raju, et al.. (2010). Combination of Anti-IGF-1R Antibody A12 and Ionizing Radiation in Upper Respiratory Tract Cancers. International Journal of Radiation Oncology*Biology*Physics. 79(4). 1179–1187. 33 indexed citations
20.
Riesterer, Oliver, Fumihiko Matsumoto, Li Wang, et al.. (2009). A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe. Investigational New Drugs. 29(3). 514–522. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hoa Q. Trummell Breakdown of academic impact, for papers by Konrad Klinghammer Breakdown of academic impact, for papers by Elvire Pons‐Tostivint Breakdown of academic impact, for papers by Zizhen Feng Breakdown of academic impact, for papers by Vincent J. Bakanauskas Breakdown of academic impact, for papers by Ulla Kasten-Pisula Breakdown of academic impact, for papers by Mariko Mihara Breakdown of academic impact, for papers by Bernhard Heinrich Breakdown of academic impact, for papers by A. D. Colevas
Rankless by CCL
2026